title: Pregnancy in patients with well-treated beta-thalassemia: outcome for mothers and newborn infants.
abstract: OBJECTIVE
  Our purpose was to investigate the course and outcome of pregnancy in women with well-treated beta-thalassemia.
  
  
  METHODS
  Twenty-two pregnancies, including one twin pregnancy, in 19 women were studied. Pregnancy was advised when patients had received a prolonged intensive treatment with hypertransfusions and iron chelation and had echocardiographically normal resting left ventricular performance. All conceptions were spontaneous. Cardiac function, along with hematologic, endocrinologic, and hepatic parameters were initially assessed and monitored throughout pregnancy and for 2 to 9 years post partum. Babies were delivered by elective cesarean section.
  
  
  RESULTS
  Twenty-one healthy newborn infants were delivered. A spontaneous abortion and a case of exomphalos also occurred. Gestation, delivery, and recovery were surprisingly uneventful, and no significant cardiac complications were encountered.
  
  
  CONCLUSIONS
  Pregnancy can be safe for mothers and babies, provided that women with thalassemia have been started early on intensive treatment and have a normal resting cardiac performance.
authors.affiliation: First Department of Internal Medicine, University of Athens School of Medicine and "Laiko" General Hospital, Athens, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Aessopos
authors.forename: F
authors.initials: F
authors.lastname: Karabatsos
authors.forename: D
authors.initials: D
authors.lastname: Farmakis
authors.forename: A
authors.initials: A
authors.lastname: Katsantoni
authors.forename: A
authors.initials: A
authors.lastname: Hatziliami
authors.forename: J
authors.initials: J
authors.lastname: Youssef
authors.forename: M
authors.initials: M
authors.lastname: Karagiorga
mesh_terms: D000328:Adult; D001803:Blood Transfusion; D002585:Cesarean Section; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000503:physiopathology; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D007231:Infant, Newborn; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008099:Liver / Q000503:physiopathology; D008297:Male; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011256:Pregnancy Outcome; D016277:Ventricular Function, Left; D017086:beta-Thalassemia / Q000150:complications* / Q000503:physiopathology / Q000628:therapy